机译:随机 2 期 LEO 试验的最终结果和依维莫司对绝经前激素受体阳性、HER2 阴性转移性乳腺癌的骨保护作用
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South;
bone turnover markers; breast cancer; everolimus; hormone receptor-positive; premenopausal women;
机译:Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials
机译:Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03)
机译:Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)